282 related articles for article (PubMed ID: 30062673)
1. Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases.
Villar-Piqué A; Schmitz M; Lachmann I; Karch A; Calero O; Stehmann C; Sarros S; Ladogana A; Poleggi A; Santana I; Ferrer I; Mitrova E; Žáková D; Pocchiari M; Baldeiras I; Calero M; Collins SJ; Geschwind MD; Sánchez-Valle R; Zerr I; Llorens F
Mol Neurobiol; 2019 Apr; 56(4):2811-2821. PubMed ID: 30062673
[TBL] [Abstract][Full Text] [Related]
2. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases.
Schmitz M; Lüllmann K; Zafar S; Ebert E; Wohlhage M; Oikonomou P; Schlomm M; Mitrova E; Beekes M; Zerr I
Neurobiol Aging; 2014 May; 35(5):1177-88. PubMed ID: 24360565
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic diversity of genetic Creutzfeldt-Jakob disease: a histo-molecular-based classification.
Baiardi S; Rossi M; Mammana A; Appleby BS; Barria MA; Calì I; Gambetti P; Gelpi E; Giese A; Ghetti B; Herms J; Ladogana A; Mikol J; Pal S; Ritchie DL; Ruf V; Windl O; Capellari S; Parchi P
Acta Neuropathol; 2021 Oct; 142(4):707-728. PubMed ID: 34324063
[TBL] [Abstract][Full Text] [Related]
4. Plasma total prion protein as a potential biomarker for neurodegenerative dementia: diagnostic accuracy in the spectrum of prion diseases.
Llorens F; Villar-Piqué A; Schmitz M; Diaz-Lucena D; Wohlhage M; Hermann P; Goebel S; Schmidt I; Glatzel M; Hauw JJ; Sikorska B; Liberski PP; Riggert J; Ferrer I; Zerr I
Neuropathol Appl Neurobiol; 2020 Apr; 46(3):240-254. PubMed ID: 31216593
[TBL] [Abstract][Full Text] [Related]
5. Relationships between clinicopathological features and cerebrospinal fluid biomarkers in Japanese patients with genetic prion diseases.
Higuma M; Sanjo N; Satoh K; Shiga Y; Sakai K; Nozaki I; Hamaguchi T; Nakamura Y; Kitamoto T; Shirabe S; Murayama S; Yamada M; Tateishi J; Mizusawa H
PLoS One; 2013; 8(3):e60003. PubMed ID: 23555862
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Human Cerebrospinal Fluid Malate Dehydrogenase 1 as a Marker in Genetic Prion Disease Patients.
Zerr I; Villar-Piqué A; Schmitz VE; Poleggi A; Pocchiari M; Sánchez-Valle R; Calero M; Calero O; Baldeiras I; Santana I; Kovacs GG; Llorens F; Schmitz M
Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31795176
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases.
Schmitz M; Villar-Piqué A; Hermann P; Escaramís G; Calero M; Chen C; Kruse N; Cramm M; Golanska E; Sikorska B; Liberski PP; Pocchiari M; Lange P; Stehmann C; Sarros S; Martí E; Baldeiras I; Santana I; Žáková D; Mitrová E; Dong XP; Collins S; Poleggi A; Ladogana A; Mollenhauer B; Kovacs GG; Geschwind MD; Sánchez-Valle R; Zerr I; Llorens F
Brain; 2022 Apr; 145(2):700-712. PubMed ID: 35288744
[TBL] [Abstract][Full Text] [Related]
8. Fluid Biomarkers in Individuals at Risk for Genetic Prion Disease up to Disease Conversion.
Vallabh SM; Mortberg MA; Allen SW; Kupferschmid AC; Kivisakk P; Hammerschlag BL; Bolling A; Trombetta BA; Devitte-McKee K; Ford AM; Sather LE; Duffy G; Rivera A; Gerber J; McManus AJ; Minikel EV; Arnold SE
Neurology; 2024 Jul; 103(2):e209506. PubMed ID: 38896810
[TBL] [Abstract][Full Text] [Related]
9. Genetic Prion Disease: Insight from the Features and Experience of China National Surveillance for Creutzfeldt-Jakob Disease.
Shi Q; Chen C; Xiao K; Zhou W; Gao LP; Chen DD; Wu YZ; Wang Y; Hu C; Gao C; Dong XP
Neurosci Bull; 2021 Nov; 37(11):1570-1582. PubMed ID: 34487324
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Accuracy of Prion Disease Biomarkers in Iatrogenic Creutzfeldt-Jakob Disease.
Llorens F; Villar-Piqué A; Hermann P; Schmitz M; Calero O; Stehmann C; Sarros S; Moda F; Ferrer I; Poleggi A; Pocchiari M; Catania M; Klotz S; O'Regan C; Brett F; Heffernan J; Ladogana A; Collins SJ; Calero M; Kovacs GG; Zerr I
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32059611
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases.
Zerr I; Schmitz M; Karch A; Villar-Piqué A; Kanata E; Golanska E; Díaz-Lucena D; Karsanidou A; Hermann P; Knipper T; Goebel S; Varges D; Sklaviadis T; Sikorska B; Liberski PP; Santana I; Ferrer I; Zetterberg H; Blennow K; Calero O; Calero M; Ladogana A; Sánchez-Valle R; Baldeiras I; Llorens F
Alzheimers Dement; 2018 Jun; 14(6):751-763. PubMed ID: 29391125
[TBL] [Abstract][Full Text] [Related]
12. Hereditary Human Prion Diseases: an Update.
Schmitz M; Dittmar K; Llorens F; Gelpi E; Ferrer I; Schulz-Schaeffer WJ; Zerr I
Mol Neurobiol; 2017 Aug; 54(6):4138-4149. PubMed ID: 27324792
[TBL] [Abstract][Full Text] [Related]
13. Preventive or promotive effects of
Kai H; Teruya K; Takeuchi A; Nakamura Y; Mizusawa H; Yamada M; Kitamoto T
Heliyon; 2023 Mar; 9(3):e13974. PubMed ID: 36915552
[TBL] [Abstract][Full Text] [Related]
14. Codon 129 polymorphism and the E200K mutation do not affect the cellular prion protein isoform composition in the cerebrospinal fluid from patients with Creutzfeldt-Jakob disease.
Schmitz M; Schlomm M; Hasan B; Beekes M; Mitrova E; Korth C; Breil A; Carimalo J; Gawinecka J; Varges D; Zerr I
Eur J Neurosci; 2010 Jun; 31(11):2024-31. PubMed ID: 20529115
[TBL] [Abstract][Full Text] [Related]
15. TREM2 expression in the brain and biological fluids in prion diseases.
Diaz-Lucena D; Kruse N; Thüne K; Schmitz M; Villar-Piqué A; da Cunha JEG; Hermann P; López-Pérez Ó; Andrés-Benito P; Ladogana A; Calero M; Vidal E; Riggert J; Pineau H; Sim V; Zetterberg H; Blennow K; Del Río JA; Marín-Moreno A; Espinosa JC; Torres JM; Sánchez-Valle R; Mollenhauer B; Ferrer I; Zerr I; Llorens F
Acta Neuropathol; 2021 Jun; 141(6):841-859. PubMed ID: 33881612
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic value of human prion detection in cerebrospinal fluid.
Foutz A; Appleby BS; Hamlin C; Liu X; Yang S; Cohen Y; Chen W; Blevins J; Fausett C; Wang H; Gambetti P; Zhang S; Hughson A; Tatsuoka C; Schonberger LB; Cohen ML; Caughey B; Safar JG
Ann Neurol; 2017 Jan; 81(1):79-92. PubMed ID: 27893164
[TBL] [Abstract][Full Text] [Related]
17. Transgenic mice recapitulate the phenotypic heterogeneity of genetic prion diseases without developing prion infectivity: Role of intracellular PrP retention in neurotoxicity.
Chiesa R; Restelli E; Comerio L; Del Gallo F; Imeri L
Prion; 2016 Mar; 10(2):93-102. PubMed ID: 26864450
[TBL] [Abstract][Full Text] [Related]
18. Prion Mutations in Republic of Republic of Korea, China, and Japan.
Kim DY; Shim KH; Bagyinszky E; An SSA
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614069
[TBL] [Abstract][Full Text] [Related]
19. [Genetic background of human prion diseases].
Kovács GG
Ideggyogy Sz; 2007 Nov; 60(11-12):438-46. PubMed ID: 18198790
[TBL] [Abstract][Full Text] [Related]
20. Characteristic CSF prion seeding efficiency in humans with prion diseases.
Cramm M; Schmitz M; Karch A; Zafar S; Varges D; Mitrova E; Schroeder B; Raeber A; Kuhn F; Zerr I
Mol Neurobiol; 2015 Feb; 51(1):396-405. PubMed ID: 24809690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
